We conducted an additional analysis using the data from the post-marketing surveillance of Alglucosidase alfa for Pompe disease. We aimed to investigate the changes in the percentage of predicted forced vital capacity (%FVC) and the changes in the distance of the 6-min walk test (6MWT) by overall improvement and to investigate the %FVC change by the duration from symptom onset to survey registration (shorter/longer groups) using a linear mixed model. Thirty-seven and eighteen survey participants had %FVC and 6MWT data available, respectively; of the patients whose overall improvement was rated as "relatively improved," %FVC and 6MWT worsened in 71.4% and 66.7%, respectively. The %FVC at the survey registration estimated using a linear mixed model was significantly higher in the shorter group than in the longer group (P = 0.0413). The estimated slope of %FVC was significantly lower in the shorter group than in the longer group (P = 0.0051). These results suggest the importance of early treatment initiation and quantitative evaluation of each symptom.
{"title":"[Importance of early treatment and quantitative evaluation of enzyme replacement therapy for Pompe disease: alglucosidase alfa post-marketing surveillance additional analysis].","authors":"Yoshinori Sunaga, Tatsuro Sakashita, Tadashi Koga, Takayuki Sawada, Shiho Yamane, Mitsunobu Ikeda","doi":"10.5692/clinicalneurol.cn-001894","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-001894","url":null,"abstract":"<p><p>We conducted an additional analysis using the data from the post-marketing surveillance of Alglucosidase alfa for Pompe disease. We aimed to investigate the changes in the percentage of predicted forced vital capacity (%FVC) and the changes in the distance of the 6-min walk test (6MWT) by overall improvement and to investigate the %FVC change by the duration from symptom onset to survey registration (shorter/longer groups) using a linear mixed model. Thirty-seven and eighteen survey participants had %FVC and 6MWT data available, respectively; of the patients whose overall improvement was rated as \"relatively improved,\" %FVC and 6MWT worsened in 71.4% and 66.7%, respectively. The %FVC at the survey registration estimated using a linear mixed model was significantly higher in the shorter group than in the longer group (P = 0.0413). The estimated slope of %FVC was significantly lower in the shorter group than in the longer group (P = 0.0051). These results suggest the importance of early treatment initiation and quantitative evaluation of each symptom.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-21DOI: 10.5692/clinicalneurol.cn-002021
Ichiro Naoi, Hiroshi Aino
This study aims to quantify the economic burden of Parkinson's disease (PD) in Japan. We conducted a targeted literature review and extracted data on the direct medical costs and long-term care costs of PD patients based on their severity, as categorized by the Hoehn and Yahr (HY) disease severity scale. These costs were estimated using information from literature sources and governmental statistics. The mean annual long-term care costs for HY1 to 5 were estimated: JPY 333 433, 527 194, 982 578, 2 023 735, and 3 080 743, respectively. These estimates were based on a cross table of HY severity and designated grade of long-term care, which was extracted from a survey of PD patients in Tokyo conducted in 2017 and national statistics on long-term care expenditure per person in June 2023. Assuming that the number of PD patients in Japan is 200,000, the annual costs for direct medical, long-term care, and the total are estimated approximately JPY 380, 270, and 650 billion, respectively. These results suggest that PD requires a significant amount of long-term care resources.
{"title":"[Economic burden of Parkinson's disease in Japan: long-term care expenditure for PD patients].","authors":"Ichiro Naoi, Hiroshi Aino","doi":"10.5692/clinicalneurol.cn-002021","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002021","url":null,"abstract":"<p><p>This study aims to quantify the economic burden of Parkinson's disease (PD) in Japan. We conducted a targeted literature review and extracted data on the direct medical costs and long-term care costs of PD patients based on their severity, as categorized by the Hoehn and Yahr (HY) disease severity scale. These costs were estimated using information from literature sources and governmental statistics. The mean annual long-term care costs for HY1 to 5 were estimated: JPY 333 433, 527 194, 982 578, 2 023 735, and 3 080 743, respectively. These estimates were based on a cross table of HY severity and designated grade of long-term care, which was extracted from a survey of PD patients in Tokyo conducted in 2017 and national statistics on long-term care expenditure per person in June 2023. Assuming that the number of PD patients in Japan is 200,000, the annual costs for direct medical, long-term care, and the total are estimated approximately JPY 380, 270, and 650 billion, respectively. These results suggest that PD requires a significant amount of long-term care resources.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142682939","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-17DOI: 10.5692/clinicalneurol.cn-002012
Syuichi Tetsuka
{"title":"[Is the frequency of head MRI lesions reduced in Wernicke's encephalopathy associated with alcoholism?]","authors":"Syuichi Tetsuka","doi":"10.5692/clinicalneurol.cn-002012","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002012","url":null,"abstract":"","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649229","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"[Is the frequency of head MRI lesions reduced in Wernicke's encephalopathy associated with alcoholism?]","authors":"Daisuke Kuzume, Yuko Morimoto, Satoshi Tsutsumi, Masahiro Yamasaki, Naohisa Hosomi","doi":"10.5692/clinicalneurol.cn-002032","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002032","url":null,"abstract":"","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649242","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
We retrospectively investigated mechanical thrombectomy (MT) in nonagenarians and older with cerebral infarction. Analysis of 21 consecutive patients showed favorable outcomes (improved modified Rankin scale [mRS] 0-2 or returned prestroke mRS) in 33.3% and poor outcome (mRS 5 or 6) in 52.4%. Factors related to favorable outcomes remain unknown, but the overall results of MT were good. MT is effective for the treatment of very elderly patients and further research is required to predict prognosis.
{"title":"[A retrospective study of mechanical thrombectomy in very elderly patients over 90 years old with cerebral infarction].","authors":"Yuki Nakamura, Rintaro Yokoyama, Seiichiro Imataka, Takehiro Saga, Koichi Haraguchi, Shin Hisahara","doi":"10.5692/clinicalneurol.cn-002017","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002017","url":null,"abstract":"<p><p>We retrospectively investigated mechanical thrombectomy (MT) in nonagenarians and older with cerebral infarction. Analysis of 21 consecutive patients showed favorable outcomes (improved modified Rankin scale [mRS] 0-2 or returned prestroke mRS) in 33.3% and poor outcome (mRS 5 or 6) in 52.4%. Factors related to favorable outcomes remain unknown, but the overall results of MT were good. MT is effective for the treatment of very elderly patients and further research is required to predict prognosis.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649221","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
The Japanese Society of Neurology's Special Committee on Measures for Transition from Pediatric to Adult Health Care held a workshop to discuss the activities of the transitional care support centers (TCSCs). The following points were addressed: (1) from Kanagawa Prefecture, the activities of the TCSC, which is set up alongside the Intractable Disease Consultation Support Center and the Intractable Disease Information Coordination Center, separated from medical institutions, and the efforts addressing cases of difficult transitions and consultations where patients cannot transition from specific pediatric chronic diseases to designated intractable diseases; (2) from Nagano Prefecture, the supporting the health care transition undertaken by the neurologist as intractable disease medical coordinator, and (3) the efforts of the transitional health care support coordinator at the TCSC established at the university hospital in collaboration with the Nagano Children's Hospital and the government. For the creation of a seamless support system, we hope that the pioneering activities reported at this time will spread nationwide.
{"title":"[Initiatives for supporting the health care transition in various regions: activities of transitional care support centers].","authors":"Yoko Mochizuki, Katsuhisa Ogata, Satoko Kumada, Tomihiro Imai, Chikako Akahoshi, Akiyo Hineno, Rie Kitahara, Ichiro Yabe, Hideki Mochizuki","doi":"10.5692/clinicalneurol.cn-002033","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002033","url":null,"abstract":"<p><p>The Japanese Society of Neurology's Special Committee on Measures for Transition from Pediatric to Adult Health Care held a workshop to discuss the activities of the transitional care support centers (TCSCs). The following points were addressed: (1) from Kanagawa Prefecture, the activities of the TCSC, which is set up alongside the Intractable Disease Consultation Support Center and the Intractable Disease Information Coordination Center, separated from medical institutions, and the efforts addressing cases of difficult transitions and consultations where patients cannot transition from specific pediatric chronic diseases to designated intractable diseases; (2) from Nagano Prefecture, the supporting the health care transition undertaken by the neurologist as intractable disease medical coordinator, and (3) the efforts of the transitional health care support coordinator at the TCSC established at the university hospital in collaboration with the Nagano Children's Hospital and the government. For the creation of a seamless support system, we hope that the pioneering activities reported at this time will spread nationwide.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649227","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2024-11-16DOI: 10.5692/clinicalneurol.cn-001969
Yukito Ueda, Ko Matsuo, Kana Matsuda, Ryo Momosaki, Akihiro Shindo, Hidekazu Tomimoto
A patient with behavioral variant frontotemporal dementia presented with stereotypic speech. The 85-year-old right-handed man had progressive language disorder over 2 years, with changes in eating behavior. His verbal output consisted mainly of the stereotypic speech; his articulation was mildly distorted, but his speech was intelligible. Spontaneous speech was rare, but there was no evidence of difficulty in initiating speech or effort. MRI of the head showed atrophy of the left frontal lobe, mainly in the superior, middle, and inferior frontal gyrus. Cerebral blood flow SPECT showed decreased cerebral blood flow in the same areas and in the left basal ganglia. We diagnosed behavioral variant frontotemporal dementia based on the symptoms, progression, and lesions. The stereotypic speech was judged to be non-meaningful recurrent utterance.
{"title":"[Behavioral variant of frontotemporal dementia with stereotypic speech: a case report].","authors":"Yukito Ueda, Ko Matsuo, Kana Matsuda, Ryo Momosaki, Akihiro Shindo, Hidekazu Tomimoto","doi":"10.5692/clinicalneurol.cn-001969","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-001969","url":null,"abstract":"<p><p>A patient with behavioral variant frontotemporal dementia presented with stereotypic speech. The 85-year-old right-handed man had progressive language disorder over 2 years, with changes in eating behavior. His verbal output consisted mainly of the stereotypic speech; his articulation was mildly distorted, but his speech was intelligible. Spontaneous speech was rare, but there was no evidence of difficulty in initiating speech or effort. MRI of the head showed atrophy of the left frontal lobe, mainly in the superior, middle, and inferior frontal gyrus. Cerebral blood flow SPECT showed decreased cerebral blood flow in the same areas and in the left basal ganglia. We diagnosed behavioral variant frontotemporal dementia based on the symptoms, progression, and lesions. The stereotypic speech was judged to be non-meaningful recurrent utterance.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Posterior spinal artery (PSA) infarctions are rare and challenging to diagnose in the acute phase. Herein, we report two cases of PSA infarctions diagnosed using spinal diffusion-weighted imaging-MRI (DWI-MRI). Case 1 involved a 74-year-old male patient presenting to our hospital with right leg numbness and unsteadiness while walking. Neurological examination revealed muscle weakness in the right lower limb and decreased vibration sensation in the dermadrome below the right Th8 level. Spinal DWI-MRI showed a high-intensity signal in the posterior right Th8, leading to the diagnosis of thoracic spinal cord infarction in the PSA region. In Case 2, a 70-year-old woman visited our hospital complaining of numbness of the left hand. Neurological examination revealed left-sided paresthesia exhibiting a positive Romberg's sign. Spinal DWI-MRI showed a high-intensity signal in the right C2 level posterior region, confirming the diagnosis of cervical spinal cord infarction in the PSA region. A neurological examination for PSA infarction and highlights the usefulness of a spinal cord DWI for auxiliary diagnosis.
{"title":"[Diagnosis of posterior spinal artery infarctions using diffusion-weighted MRI].","authors":"Junichi Uemura, Saki Miyazato, Shinji Yamashita, Yoshiki Yagita, Takeshi Inoue","doi":"10.5692/clinicalneurol.cn-002011","DOIUrl":"https://doi.org/10.5692/clinicalneurol.cn-002011","url":null,"abstract":"<p><p>Posterior spinal artery (PSA) infarctions are rare and challenging to diagnose in the acute phase. Herein, we report two cases of PSA infarctions diagnosed using spinal diffusion-weighted imaging-MRI (DWI-MRI). Case 1 involved a 74-year-old male patient presenting to our hospital with right leg numbness and unsteadiness while walking. Neurological examination revealed muscle weakness in the right lower limb and decreased vibration sensation in the dermadrome below the right Th8 level. Spinal DWI-MRI showed a high-intensity signal in the posterior right Th8, leading to the diagnosis of thoracic spinal cord infarction in the PSA region. In Case 2, a 70-year-old woman visited our hospital complaining of numbness of the left hand. Neurological examination revealed left-sided paresthesia exhibiting a positive Romberg's sign. Spinal DWI-MRI showed a high-intensity signal in the right C2 level posterior region, confirming the diagnosis of cervical spinal cord infarction in the PSA region. A neurological examination for PSA infarction and highlights the usefulness of a spinal cord DWI for auxiliary diagnosis.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142649225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 65-year-old man presented to the emergency department with the complaints of left anterior chest and back pain, numbness in the left medial arm, and weakness in the left hand grip. Myocardial infarction was suspected, but later ruled out, and the patient was subsequently referred to our department. Among the intrinsic muscles, the left abductor pollicis brevis was the most severely weakened, and there was a sensory disturbance in the left T1 region and left Horner's sign. An MRI T2-weighted image of the cervical spine showed a herniated disc on the left lateral side at the T1/2 level, suggesting compression of the T1 nerve root. Cervical angina is a rare, angina-like anterior chest pain due to cervical spine diseases. It is often reported in patients with C6 and C7 radiculopathy. The most severe weakness in the abductor pollicis brevis muscle in T1 radiculopathy is important to distinguish it from C8 radiculopathy.
{"title":"[A case of T1 radiculopathy caused by intervertebral disc herniation with cervical angina].","authors":"Kazuki Sogawa, Tetsuo Ando, Yasuo Kanamori, Syunsuke Koga, Masahiro Sonoo, Toshio Fukutake","doi":"10.5692/clinicalneurol.cn-001989","DOIUrl":"10.5692/clinicalneurol.cn-001989","url":null,"abstract":"<p><p>A 65-year-old man presented to the emergency department with the complaints of left anterior chest and back pain, numbness in the left medial arm, and weakness in the left hand grip. Myocardial infarction was suspected, but later ruled out, and the patient was subsequently referred to our department. Among the intrinsic muscles, the left abductor pollicis brevis was the most severely weakened, and there was a sensory disturbance in the left T1 region and left Horner's sign. An MRI T<sub>2</sub>-weighted image of the cervical spine showed a herniated disc on the left lateral side at the T1/2 level, suggesting compression of the T1 nerve root. Cervical angina is a rare, angina-like anterior chest pain due to cervical spine diseases. It is often reported in patients with C6 and C7 radiculopathy. The most severe weakness in the abductor pollicis brevis muscle in T1 radiculopathy is important to distinguish it from C8 radiculopathy.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"725-729"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142355938","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
A 67-year-old woman with past medical history of chronic myelomonocytic leukemia (CMML) presented with a chief complaint of headache, diplopia, and hearing impairment in the right ear. Examination revealed impaired ocular movement in the left eye and sensorineural hearing loss in the right ear. Cerebrospinal fluid analysis showed increased cell count and protein, and MRI showed contrast enhancement of hypertrophic dura mater. Since there were no other abnormalities which would have been a cause of hypertrophic pachymeningitis, it was considered as systemic autoimmune/inflammatory disorder (SAID) associated with CMML. Treatment with steroid, cyclophosphamide, and methotrexate led to improvement of the symptoms. SAIDs develop in up to 25% of patients with myelodysplastic syndromes (MDS) or CMML, which may be the only symptoms of MDS/CMML. As a phenotype of SAIDs, systemic vasculitis, connective tissue diseases, and neutrophilic diseases are frequently reported; however, isolated involvement of central nerve system is rarely reported. To our knowledge, this is the first report of hypertrophic pachymeningitis as SAID associated with CMML. To clarify the pathogenesis of neurologic involvement of SAIDs, accumulation of cases is necessary.
{"title":"[A case of hypertrophic pachymeningitis as a systemic autoimmune/inflammatory disorder (SAID) associated with chronic myelomonocytic leukemia].","authors":"Tatsuya Sato, Tomoyuki Inoue, Satoshi Kubo, Kota Sato, Takahiro Himeno, Yuka Terasawa","doi":"10.5692/clinicalneurol.cn-002007","DOIUrl":"10.5692/clinicalneurol.cn-002007","url":null,"abstract":"<p><p>A 67-year-old woman with past medical history of chronic myelomonocytic leukemia (CMML) presented with a chief complaint of headache, diplopia, and hearing impairment in the right ear. Examination revealed impaired ocular movement in the left eye and sensorineural hearing loss in the right ear. Cerebrospinal fluid analysis showed increased cell count and protein, and MRI showed contrast enhancement of hypertrophic dura mater. Since there were no other abnormalities which would have been a cause of hypertrophic pachymeningitis, it was considered as systemic autoimmune/inflammatory disorder (SAID) associated with CMML. Treatment with steroid, cyclophosphamide, and methotrexate led to improvement of the symptoms. SAIDs develop in up to 25% of patients with myelodysplastic syndromes (MDS) or CMML, which may be the only symptoms of MDS/CMML. As a phenotype of SAIDs, systemic vasculitis, connective tissue diseases, and neutrophilic diseases are frequently reported; however, isolated involvement of central nerve system is rarely reported. To our knowledge, this is the first report of hypertrophic pachymeningitis as SAID associated with CMML. To clarify the pathogenesis of neurologic involvement of SAIDs, accumulation of cases is necessary.</p>","PeriodicalId":39292,"journal":{"name":"Clinical Neurology","volume":" ","pages":"742-745"},"PeriodicalIF":0.0,"publicationDate":"2024-10-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142308725","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}